Cargando…
Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure compl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438269/ https://www.ncbi.nlm.nih.gov/pubmed/32827587 http://dx.doi.org/10.1016/j.resuscitation.2020.08.006 |
_version_ | 1783572764092792832 |
---|---|
author | Coleman, Jamie J. Botkai, Adam Marson, Ella J. Evison, Felicity Atia, Jolene Wang, Jingyi Gallier, Suzy Speakman, John Pankhurst, Tanya |
author_facet | Coleman, Jamie J. Botkai, Adam Marson, Ella J. Evison, Felicity Atia, Jolene Wang, Jingyi Gallier, Suzy Speakman, John Pankhurst, Tanya |
author_sort | Coleman, Jamie J. |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR. METHODS: The study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019. RESULTS: A total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001). CONCLUSION: During the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease. |
format | Online Article Text |
id | pubmed-7438269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74382692020-08-20 Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice Coleman, Jamie J. Botkai, Adam Marson, Ella J. Evison, Felicity Atia, Jolene Wang, Jingyi Gallier, Suzy Speakman, John Pankhurst, Tanya Resuscitation Clinical Paper BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR. METHODS: The study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019. RESULTS: A total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001). CONCLUSION: During the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease. Published by Elsevier B.V. 2020-10 2020-08-20 /pmc/articles/PMC7438269/ /pubmed/32827587 http://dx.doi.org/10.1016/j.resuscitation.2020.08.006 Text en Crown Copyright © 2020 Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Paper Coleman, Jamie J. Botkai, Adam Marson, Ella J. Evison, Felicity Atia, Jolene Wang, Jingyi Gallier, Suzy Speakman, John Pankhurst, Tanya Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title | Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title_full | Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title_fullStr | Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title_full_unstemmed | Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title_short | Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice |
title_sort | bringing into focus treatment limitation and dnacpr decisions: how covid-19 has changed practice |
topic | Clinical Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438269/ https://www.ncbi.nlm.nih.gov/pubmed/32827587 http://dx.doi.org/10.1016/j.resuscitation.2020.08.006 |
work_keys_str_mv | AT colemanjamiej bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT botkaiadam bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT marsonellaj bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT evisonfelicity bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT atiajolene bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT wangjingyi bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT galliersuzy bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT speakmanjohn bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice AT pankhursttanya bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice |